EU Age Related Macular Degeneration Therapeutics Market, by Disease Type (Dry Eye and Wet Eye) by Drug type (Aflibercept (Eylea), Ranibizumab (Lucentis), Bevacizumab (Avastin), Pegaptanib (Macugen), Verteporfin (Visudyne), Brolucizumab (Beovu), Supplements, and Others) and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138181
- Pages: 200
-
Format:
Report Overview
The EU Age-related macular degeneration therapeutics market size stood at around USD $0.9 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
Age-related macular degeneration (AMD) also known as macular degeneration is a condition, which results in loss of central vision caused due to the thinning of the macula of the retina. Age-related macular degeneration typically occurs in the geriatric population and can cause permanent vision loss in people aged 60 years and above
Market Drivers
The increasing prevalence of age-related macular degeneration is expected to drive growth of the age-related macular degeneration therapeutics market. Approval and launch of new age-related macular degeneration therapeutics products by regulatory authorities is expected to drive the market growth during the forecast period
1. EU Age Related Macular Degeneration Therapeutics Market Overview
A. Market Size
2. EU Age Related Macular Degeneration Therapeutics Market Growth Drivers
I. Increasing prevalence of age-related macular degeneration
II. Launch and approval of new products
3. EU Age Related Macular Degeneration Therapeutics Market Segmentation.
A. By Disease Type
I. Dry Eye
II. Wet Eye
B. By Drug type
I. Aflibercept (Eylea)
II. Ranibizumab (Lucentis)
III. Bevacizumab (Avastin)
IV. Pegaptanib (Macugen)
V. Verteporfin (Visudyne)
VI. Brolucizumab (Beovu)
VII. Supplements VIII. Others
C. By Distribution Channel
I. Retail Pharmacies
II. Hospital Pharmacies
III. Online Pharmacies
4. EU Age Related Macular Degeneration Therapeutics Market Major Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Bayer AG Company overview, Product & Services, Strategies & Financials
B. Novartis AG Company overview, Product & Services, Strategies & Financials
C. Pfizer Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Market Opportunities and Future Trends
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
